| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 | 2.57e-07 | 296 | 79 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.18e-06 | 6 | 79 | 3 | GO:0008510 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 ABCC10 | 2.69e-06 | 477 | 79 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.16e-06 | 171 | 79 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.66e-05 | 13 | 79 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.79e-05 | 138 | 79 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.10e-05 | 14 | 79 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.51e-05 | 301 | 79 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 3.22e-05 | 16 | 79 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 TOMM40 PLSCR3 TMED10 SLC4A4 TTPA SLC4A5 SLC22A7 ABCC10 | 3.73e-05 | 1289 | 79 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 5.52e-05 | 19 | 79 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | mannose-ethanolamine phosphotransferase activity | 9.23e-05 | 4 | 79 | 2 | GO:0051377 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.10e-04 | 119 | 79 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.63e-04 | 27 | 79 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 TOMM40 TMED10 SLC4A4 SLC4A5 SLC22A7 ABCC10 | 1.97e-04 | 1180 | 79 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 2.29e-04 | 6 | 79 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | copper ion binding | 2.59e-04 | 78 | 79 | 4 | GO:0005507 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 2.72e-04 | 32 | 79 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.72e-04 | 32 | 79 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.00e-04 | 81 | 79 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | symporter activity | 3.22e-04 | 150 | 79 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.00e-04 | 465 | 79 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.56e-04 | 43 | 79 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CA9 GPC1 MOXD2P TRIM11 SLC11A2 CYP17A1 MARCHF5 MBD1 ZFHX2 LOXL4 PLSCR3 ZNF385C PLOD2 | 7.43e-04 | 1189 | 79 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.07e-03 | 293 | 79 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC13A3 TOMM40 SLC4A4 SLC4A5 | 1.22e-03 | 664 | 79 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.36e-03 | 14 | 79 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.57e-03 | 15 | 79 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.27e-03 | 18 | 79 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 2.53e-03 | 19 | 79 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC13A3 SLC4A4 SLC4A5 ABCC10 | 2.99e-03 | 758 | 79 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.33e-03 | 627 | 79 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 3.39e-03 | 22 | 79 | 2 | GO:0016780 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC13A3 TOMM40 SLC4A4 SLC4A5 | 4.03e-03 | 793 | 79 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.66e-03 | 85 | 79 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.74e-03 | 171 | 79 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 5.47e-03 | 28 | 79 | 2 | GO:0008320 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 6.61e-08 | 94 | 78 | 7 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.09e-07 | 101 | 78 | 7 | GO:0030641 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.55e-07 | 120 | 78 | 7 | GO:0006885 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 9.44e-06 | 275 | 78 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.38e-05 | 208 | 78 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 CD19 INPP5K SLCO3A1 SLC13A3 TOMM40 SLC4A4 SLC4A5 SLC22A7 ABCC10 CNTN1 | 1.70e-04 | 1374 | 78 | 15 | GO:0006811 |
| GeneOntologyCellularComponent | basal part of cell | CA9 SLC9A1 SLC4A7 SLC11A2 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 ABCC10 | 1.77e-06 | 378 | 80 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | CA9 SLC9A1 SLC4A7 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 ABCC10 | 3.69e-06 | 320 | 80 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | CA9 SLC9A1 SLC4A7 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 ABCC10 | 8.33e-06 | 354 | 80 | 9 | GO:0009925 |
| GeneOntologyCellularComponent | lysosomal lumen | 5.47e-04 | 98 | 80 | 4 | GO:0043202 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.47e-04 | 487 | 80 | 8 | GO:0016324 | |
| MousePheno | decreased circulating bicarbonate level | 9.28e-06 | 10 | 61 | 3 | MP:0003017 | |
| MousePheno | abnormal Purkinje cell axon morphology | 2.19e-05 | 13 | 61 | 3 | MP:0014329 | |
| MousePheno | abnormal circulating bicarbonate level | 3.47e-05 | 15 | 61 | 3 | MP:0003015 | |
| MousePheno | abnormal bicarbonate level | 5.15e-05 | 17 | 61 | 3 | MP:0031394 | |
| MousePheno | abnormal bicarbonate homeostasis | 6.16e-05 | 18 | 61 | 3 | MP:0031393 | |
| Domain | NaH_exchanger | 5.34e-06 | 9 | 76 | 3 | IPR004709 | |
| Domain | Band3_cytoplasmic_dom | 5.34e-06 | 9 | 76 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 5.34e-06 | 9 | 76 | 3 | PF07565 | |
| Domain | - | 5.34e-06 | 9 | 76 | 3 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 7.61e-06 | 10 | 76 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 7.61e-06 | 10 | 76 | 3 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 7.61e-06 | 10 | 76 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 7.61e-06 | 10 | 76 | 3 | IPR003020 | |
| Domain | Cation/H_exchanger_CPA1 | 1.04e-05 | 11 | 76 | 3 | IPR018422 | |
| Domain | Na_H_Exchanger | 2.28e-05 | 14 | 76 | 3 | PF00999 | |
| Domain | Cation/H_exchanger | 2.28e-05 | 14 | 76 | 3 | IPR006153 | |
| Domain | Pecanex_C | 9.75e-05 | 4 | 76 | 2 | PF05041 | |
| Domain | Pecanex | 9.75e-05 | 4 | 76 | 2 | IPR007735 | |
| Domain | Na/HCO3_transpt | 1.62e-04 | 5 | 76 | 2 | IPR003024 | |
| Domain | ANION_EXCHANGER_2 | 3.39e-04 | 7 | 76 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 3.39e-04 | 7 | 76 | 2 | PS00219 | |
| Domain | Cadherin_tail | 4.55e-04 | 37 | 76 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 4.55e-04 | 37 | 76 | 3 | IPR031904 | |
| Domain | Cadherin_C | 6.63e-04 | 42 | 76 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 6.63e-04 | 42 | 76 | 3 | PF16492 | |
| Domain | Phosphodiest | 7.20e-04 | 10 | 76 | 2 | PF01663 | |
| Domain | Phosphodiest/P_Trfase | 7.20e-04 | 10 | 76 | 2 | IPR002591 | |
| Domain | Cadherin_2 | 2.36e-03 | 65 | 76 | 3 | PF08266 | |
| Domain | Cadherin_N | 2.36e-03 | 65 | 76 | 3 | IPR013164 | |
| Domain | - | 2.96e-03 | 20 | 76 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 3.26e-03 | 21 | 76 | 2 | IPR003594 | |
| Domain | fn3 | 4.31e-03 | 162 | 76 | 4 | PF00041 | |
| Domain | FN3 | 6.87e-03 | 185 | 76 | 4 | SM00060 | |
| Domain | Alkaline_phosphatase_core | 7.04e-03 | 31 | 76 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 7.04e-03 | 31 | 76 | 2 | IPR017849 | |
| Domain | - | 7.04e-03 | 31 | 76 | 2 | 3.40.720.10 | |
| Domain | FN3 | 8.83e-03 | 199 | 76 | 4 | PS50853 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 | 2.35e-09 | 238 | 57 | 11 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 | 3.77e-09 | 249 | 57 | 11 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 LCAT SLC4A4 SLC4A5 SLC22A7 ABCC10 | 2.38e-06 | 681 | 57 | 13 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.65e-06 | 108 | 57 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.90e-06 | 109 | 57 | 6 | MM15074 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.18e-06 | 9 | 57 | 3 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.18e-06 | 9 | 57 | 3 | MM15079 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 LCAT SLC4A4 SLC4A5 SLC22A7 ABCC10 | 5.58e-06 | 736 | 57 | 13 | M27287 |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 7.37e-06 | 10 | 57 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 7.37e-06 | 10 | 57 | 3 | MM15073 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 5.99e-04 | 41 | 57 | 3 | M27257 | |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 21705333 | ||
| Pubmed | The Na+/HCO3- co-transporter is protective during ischemia in astrocytes. | 5.36e-06 | 2 | 81 | 2 | 27717805 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28319329 | ||
| Pubmed | Role of an extracellular loop in determining the stoichiometry of Na+-HCO₃⁻ cotransporters. | 5.36e-06 | 2 | 81 | 2 | 21224233 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20542029 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22383045 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12598940 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28055960 | ||
| Pubmed | NBC3 expression in rabbit collecting duct: colocalization with vacuolar H+-ATPase. | 5.36e-06 | 2 | 81 | 2 | 10600945 | |
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 6.67e-06 | 16 | 81 | 3 | 35307651 | |
| Pubmed | 9.68e-06 | 18 | 81 | 3 | 24874739 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 37932447 | ||
| Pubmed | Chaperone stress 70 protein (STCH) binds and regulates two acid/base transporters NBCe1-B and NHE1. | 1.60e-05 | 3 | 81 | 2 | 23303189 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28992603 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22120673 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25241983 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23421592 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GPC1 PIGN MYADM MIA2 MAN2B1 GINM1 ERP29 TMED10 TOR3A PLOD2 PIGO SORL1 | 2.14e-05 | 1201 | 81 | 12 | 35696571 |
| Pubmed | Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes. | 3.20e-05 | 4 | 81 | 2 | 16938836 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 28327575 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 17077994 | ||
| Pubmed | Distribution of organic anion transporters NaDC3 and OAT1-3 along the human nephron. | 3.20e-05 | 4 | 81 | 2 | 27053689 | |
| Pubmed | GPI7 is the second partner of PIG-F and involved in modification of glycosylphosphatidylinositol. | 3.20e-05 | 4 | 81 | 2 | 15632136 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20432167 | ||
| Pubmed | Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. | 3.20e-05 | 4 | 81 | 2 | 17715183 | |
| Pubmed | Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. | 3.20e-05 | 4 | 81 | 2 | 26809508 | |
| Pubmed | GPC1 MAN2B1 VANGL1 SMCHD1 MDC1 ERP29 TOMM40 TMED10 TOR3A BRAT1 PLOD2 PIGO | 4.52e-05 | 1297 | 81 | 12 | 33545068 | |
| Pubmed | Close linkage of three neuronal genes on distal mouse chromosome 15. | 5.33e-05 | 5 | 81 | 2 | 8703126 | |
| Pubmed | Dynamic Regulation of Mitochondrial Import by the Ubiquitin System. | 5.33e-05 | 5 | 81 | 2 | 32142684 | |
| Pubmed | Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. | 7.99e-05 | 6 | 81 | 2 | 19015200 | |
| Pubmed | Polymorphisms associated with circulating sex hormone levels in postmenopausal women. | 7.99e-05 | 6 | 81 | 2 | 15199113 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 16896040 | ||
| Pubmed | CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. | 1.12e-04 | 7 | 81 | 2 | 18318428 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 12576672 | ||
| Pubmed | Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. | 1.12e-04 | 7 | 81 | 2 | 26276629 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 23565137 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 23677982 | ||
| Pubmed | 1.41e-04 | 212 | 81 | 5 | 19521566 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 27856754 | ||
| Pubmed | Genome-wide analysis of genetic loci associated with Alzheimer disease. | 1.49e-04 | 8 | 81 | 2 | 20460622 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.72e-04 | 857 | 81 | 9 | 25609649 | |
| Pubmed | Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. | 1.91e-04 | 9 | 81 | 2 | 32522871 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 18767927 | ||
| Pubmed | Familial pure proximal renal tubular acidosis--a clinical and genetic study. | 1.91e-04 | 9 | 81 | 2 | 17881426 | |
| Pubmed | Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. | 1.91e-04 | 9 | 81 | 2 | 18980759 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 20173016 | ||
| Pubmed | ILC3s control splenic cDC homeostasis via lymphotoxin signaling. | 1.91e-04 | 9 | 81 | 2 | 33724364 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 24755620 | ||
| Pubmed | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | 3.97e-04 | 61 | 81 | 3 | 18464913 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 16403838 | ||
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 5.24e-04 | 67 | 81 | 3 | 22321011 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 5.47e-04 | 68 | 81 | 3 | 11230163 | |
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 28112518 | ||
| Pubmed | 5.98e-04 | 164 | 81 | 4 | 32409323 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 6.46e-04 | 72 | 81 | 3 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 7.00e-04 | 74 | 81 | 3 | 10817752 | |
| Pubmed | Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. | 7.12e-04 | 17 | 81 | 2 | 11102867 | |
| Pubmed | 7.14e-04 | 172 | 81 | 4 | 27375898 | ||
| Pubmed | 7.78e-04 | 176 | 81 | 4 | 28692057 | ||
| Pubmed | 7.86e-04 | 77 | 81 | 3 | 10835267 | ||
| Pubmed | 8.00e-04 | 18 | 81 | 2 | 12684764 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 8.79e-04 | 80 | 81 | 3 | 10716726 | |
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 20716560 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.09e-03 | 21 | 81 | 2 | 25249183 | |
| Pubmed | A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. | 1.20e-03 | 22 | 81 | 2 | 12417987 | |
| Pubmed | Reprogramming of Sertoli cells to fetal-like Leydig cells by Wt1 ablation. | 1.31e-03 | 23 | 81 | 2 | 25775596 | |
| Pubmed | 1.32e-03 | 92 | 81 | 3 | 20301317 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 1.41e-03 | 925 | 81 | 8 | 28986522 | |
| Pubmed | Rhox8 homeobox gene ablation leads to rete testis abnormality and male subfertility in mice†. | 1.43e-03 | 24 | 81 | 2 | 37471646 | |
| Pubmed | 1.55e-03 | 25 | 81 | 2 | 17507624 | ||
| Pubmed | 1.58e-03 | 1168 | 81 | 9 | 19946888 | ||
| Pubmed | Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. | 1.68e-03 | 26 | 81 | 2 | 19060910 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 1.72e-03 | 101 | 81 | 3 | 20587610 | |
| Pubmed | Family-based analysis of candidate genes for polycystic ovary syndrome. | 1.81e-03 | 27 | 81 | 2 | 20200332 | |
| Pubmed | Conditionals by inversion provide a universal method for the generation of conditional alleles. | 1.81e-03 | 27 | 81 | 2 | 23918385 | |
| Pubmed | 1.92e-03 | 105 | 81 | 3 | 30280653 | ||
| Pubmed | 1.95e-03 | 28 | 81 | 2 | 28057766 | ||
| Pubmed | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. | 2.09e-03 | 29 | 81 | 2 | 21909115 | |
| Pubmed | 2.09e-03 | 29 | 81 | 2 | 24003143 | ||
| Pubmed | 2.23e-03 | 30 | 81 | 2 | 34745083 | ||
| Interaction | PRG2 interactions | 1.19e-05 | 285 | 76 | 8 | int:PRG2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.79e-04 | 346 | 81 | 5 | chr17p13 | |
| Cytoband | 16q22.1 | 9.97e-04 | 110 | 81 | 3 | 16q22.1 | |
| Cytoband | 5q31 | 1.13e-03 | 115 | 81 | 3 | 5q31 | |
| GeneFamily | Solute carriers | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SLC11A2 SLC2A7 SLCO3A1 SLC13A3 SLC4A4 SLC4A5 SLC22A7 | 2.90e-08 | 395 | 56 | 11 | 752 |
| GeneFamily | Clustered protocadherins | 1.03e-03 | 64 | 56 | 3 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 1.52e-03 | 160 | 56 | 4 | 555 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 1.91e-03 | 21 | 56 | 2 | 680 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.38e-03 | 181 | 56 | 4 | 694 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN | 3.11e-05 | 199 | 79 | 6 | M8861 | |
| Coexpression | GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 3.20e-05 | 200 | 79 | 6 | M8547 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_LUNG_UP | 3.20e-05 | 200 | 79 | 6 | M4368 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_100 | 6.82e-06 | 34 | 77 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_100_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_100 | 2.32e-05 | 46 | 77 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_100 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.37e-07 | 176 | 81 | 6 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2_progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.30e-06 | 125 | 81 | 5 | b5fed0e0295aa8ad323c318b59bf23cde3e758c8 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 1.00e-05 | 157 | 81 | 5 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 1.07e-05 | 159 | 81 | 5 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 161 | 81 | 5 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-05 | 169 | 81 | 5 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-05 | 178 | 81 | 5 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 181 | 81 | 5 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-05 | 183 | 81 | 5 | a742c9a33f32058f9fb051733e3e736bc704d8e6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-05 | 185 | 81 | 5 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-05 | 185 | 81 | 5 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-05 | 191 | 81 | 5 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.85e-05 | 195 | 81 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 197 | 81 | 5 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 198 | 81 | 5 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| Drug | bumetanide | 7.25e-07 | 209 | 80 | 8 | CID000002471 | |
| Drug | EIPA | 1.05e-06 | 95 | 80 | 6 | CID000001795 | |
| Drug | benzolamide | 2.71e-06 | 28 | 80 | 4 | CID000018794 | |
| Drug | AC1L2E5V | 3.14e-06 | 29 | 80 | 4 | CID000019458 | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 4.96e-06 | 191 | 80 | 7 | 7542_UP | |
| Drug | HOE 694 | 8.54e-06 | 37 | 80 | 4 | CID000123840 | |
| Drug | AC1L9M3Z | 9.52e-06 | 38 | 80 | 4 | CID000448575 | |
| Drug | ethoxzolamide | 1.17e-05 | 40 | 80 | 4 | CID000003295 | |
| Drug | cariporide | 1.32e-05 | 86 | 80 | 5 | CID000151172 | |
| Drug | AC1L8Y60 | 1.55e-05 | 89 | 80 | 5 | CID000410009 | |
| Drug | bicarbonate | 1.88e-05 | 325 | 80 | 8 | CID000000767 | |
| Drug | 3-methylsulfonyl-4-piperidinobenzoyl guanidine | 3.65e-05 | 3 | 80 | 2 | ctd:C074107 | |
| Drug | cimetidine | 4.03e-05 | 179 | 80 | 6 | CID000002756 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.16e-05 | 180 | 80 | 6 | 1076_DN | |
| Drug | triamterene | 5.19e-05 | 58 | 80 | 4 | CID000005546 | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A | 5.78e-05 | 191 | 80 | 6 | 7547_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 5.78e-05 | 191 | 80 | 6 | 6959_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 6.31e-05 | 194 | 80 | 6 | 2735_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 2701_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6146_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6795_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6661_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7048_UP | |
| Drug | Betulin [473-98-3]; Down 200; 9uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2952_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2963_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 490_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3270_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 7076_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; PC3; HG-U133A | 7.06e-05 | 198 | 80 | 6 | 702_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 2550_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 1509_DN | |
| Drug | sodium | SLC9A8 SLC9A1 SLC9A5 SLC4A7 SACS ASMTL SLC2A7 SLCO3A1 SLC13A3 ERP29 SLC4A4 SLC4A5 | 1.08e-04 | 944 | 80 | 12 | CID000000923 |
| Drug | amiloride | 1.22e-04 | 315 | 80 | 7 | CID000016230 | |
| Drug | BCECF | 1.28e-04 | 73 | 80 | 4 | CID004241719 | |
| Drug | sodium bicarbonate | 1.35e-04 | 74 | 80 | 4 | CID000010340 | |
| Disease | anemia (implicated_via_orthology) | 8.21e-06 | 15 | 79 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 7.04e-05 | 5 | 79 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.34e-04 | 206 | 79 | 5 | C0152013 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 9.26e-04 | 71 | 79 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | family history of Alzheimer’s disease | 9.26e-04 | 71 | 79 | 3 | EFO_0009268 | |
| Disease | mental development measurement | 2.04e-03 | 25 | 79 | 2 | EFO_0008230 | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 2.04e-03 | 25 | 79 | 2 | EFO_0004612, EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLVFLTPIAFILLPP | 121 | Q8TAA9 | |
| TLFPAPILGPALFRT | 391 | Q66K41 | |
| PRPSFCLSLPLFLGR | 366 | Q2M3D2 | |
| GPLIPQFLRELFPVL | 491 | Q6PJG6 | |
| PLIPIFLLLLFGPCI | 521 | Q9N2J8 | |
| RGPPPLLLFLGAALV | 11 | O95196 | |
| PGAPLPALFLLALAL | 6 | Q6UXT8 | |
| PLEFLRRVPLGFSAP | 531 | Q7Z2Z2 | |
| PRAAFLSPLLPLLLG | 6 | P30040 | |
| RLPLPSFLLLPFQRI | 546 | O94989 | |
| ALRPLELLGFQLPPL | 176 | Q16790 | |
| PRIMPPLLLLSAFIF | 16 | Q6ZRI8 | |
| AGPRQVLFPLLLPLF | 11 | Q9Y5F9 | |
| AGPRQVLFPLLLPLF | 11 | Q9Y5F8 | |
| PPFFLLLGIPGLDTL | 11 | Q8NGH9 | |
| RGPLALALVALLPAP | 131 | Q5T3U5 | |
| PLLLVGFSLPLARAL | 6 | P23469 | |
| FPHLRPVLFLLLLGV | 21 | Q8NH08 | |
| PATLFLFLLLLGQPP | 6 | Q96JB6 | |
| IPLRVGLPLLSPEFL | 2051 | Q14676 | |
| LVPLLLLPGSYGLPF | 6 | Q96S86 | |
| GVPALLQLLTLPFFP | 206 | Q6PXP3 | |
| QPPTFLLPLLLFLAL | 536 | P35052 | |
| PGSLALRLLLFVALP | 6 | Q9NU53 | |
| LPPFPTRLLELIEGF | 281 | O95671 | |
| FGKRCFDLIPLLPLP | 436 | Q6ZVZ8 | |
| GFVLPPPGTDLVFLR | 446 | Q9UIS9 | |
| RPFVIPFLKANLPLL | 171 | O43439 | |
| FLLLLPLALHLAFPP | 41 | A6NKB5 | |
| LSSPLLPLFTLPVFL | 586 | Q63HM2 | |
| LPLFTLPVFLVGFPR | 591 | Q63HM2 | |
| FLPLPGVPSGLEFLV | 66 | Q9NRY6 | |
| VLLPFLLSLFPGALP | 16 | Q9Y5G2 | |
| FLGVPFSRPPLGILR | 51 | Q5XG92 | |
| RADPLFLLIGLPTIP | 136 | Q9NX47 | |
| VLPIPFPSFLSGLAL | 231 | Q96S97 | |
| PFALIPILTFTSLRP | 451 | P49281 | |
| PPRGFPGLILLTVLL | 211 | Q86SM8 | |
| QPTPFLPRFLDILLT | 306 | O00469 | |
| ILLGELARAFFPAPP | 86 | Q96GM1 | |
| MPPPRLLFFLLFLTP | 1 | P15391 | |
| LLSLPLVGSLPFLPR | 31 | P05093 | |
| PLLREFQEGRLLFPP | 231 | Q9BT40 | |
| PTLSPSLLGLLLPAF | 996 | Q12860 | |
| LPFTSLLFLQLPLLG | 6 | P31785 | |
| RALRPPLPPLCFFLL | 26 | O00754 | |
| PLPPLCFFLLLLAAA | 31 | O00754 | |
| VTLLLGLLLPPAAPF | 11 | P04180 | |
| LRPAPALLAPAVLLG | 21 | P57679 | |
| LPRVLLPLHFLLPIF | 26 | Q9Y694 | |
| LFTPLALLPVVFALP | 21 | Q8WWT9 | |
| TEFLTPGLRSIPPLF | 4266 | Q9NZJ4 | |
| LGFPAPAPLQVLLFA | 16 | O95222 | |
| FPFPLPKSLERLLLG | 156 | Q99983 | |
| AFLSPPTLLEGPLRL | 1141 | Q96PC5 | |
| LFRLFPLLALGVPLQ | 6 | A6NHM9 | |
| PLIGFLLSIPRLPSM | 441 | O43196 | |
| RLPFLFTLVALLPPG | 11 | Q92673 | |
| RLPLLAGFFLPGLFL | 281 | Q9NRR2 | |
| VPVPTRFLFLLLGPA | 461 | Q9Y6M7 | |
| LDLPFRVGVPFNIPL | 831 | A6NHR9 | |
| VLFLLLRLLGFIPPP | 576 | Q9UIG8 | |
| LRLLGFIPPPLIFGA | 581 | Q9UIG8 | |
| LLGPKPFPLDRLLAI | 351 | O43913 | |
| FAFRLPAPPIGGALL | 221 | Q9H7J1 | |
| LFPASNLRLPLVPAL | 176 | P04278 | |
| FRPNMFFLLLLPPII | 121 | Q9Y2E8 | |
| QLEPGTFFLFLLPPI | 101 | Q14940 | |
| RLPGLLLSPECIFPF | 66 | Q9P0P8 | |
| DPRFPLPRFILLVSG | 136 | Q8WZ82 | |
| FLKPRILFPGFLCPL | 476 | Q96M02 | |
| LFPRGLFEDALPPIV | 156 | P49842 | |
| LFIFPEIPFSGTLRP | 426 | Q96F44 | |
| TVPALLGGQFLPFPL | 2336 | Q9C0A1 | |
| RGPFPLALLLLFLLG | 11 | P49755 | |
| PPFLLPILFLASHVG | 6 | P35590 | |
| SPFRALLPSPLFLIR | 586 | Q6ZQQ2 | |
| VLGTPRHIFPLPLLF | 81 | Q6ZSR6 | |
| EVPVPTRFLFILLGP | 336 | Q9BY07 | |
| LPPIILDAGYFLPLR | 166 | P19634 | |
| PLAPLPLTDSFLLRF | 41 | P49638 | |
| FTPLPPPARRLVLFV | 36 | O95427 | |
| KLPPLPLTLALGAFL | 331 | O96008 | |
| TLFPIPGPVLLLLLF | 541 | Q8TEQ8 | |
| PGPVLLLLLFRLAVF | 546 | Q8TEQ8 | |
| EVPVPTRFLFILLGP | 316 | Q9Y6R1 | |
| PAPPSFILLLFTLIA | 211 | Q8N1Y9 | |
| LFFLLLLPGAPEPRG | 11 | Q9H497 | |
| QALPLLPRELFPLLF | 21 | Q15048 |